Skip to main content
Caplight Logo









eXmoor Pharma

eXmoor Pharma

Private
BristolHealthcare & Life Scienceshttps://www.exmoorpharma.com/

Last Round

Series A

May 30, 2023

Total Funding Raised

$36.8M

Company Overview

eXmoor Pharma is a cell and gene therapy company that provides contract development and manufacturing (CDMO) services, including consultancy, process development, and GMP manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Pharma Supply Chain, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOcell and gene therapyCGTGMP manufacturingviral vector manufacturingcell therapy manufacturingprocess developmentanalytical developmentATMP manufacturingCMC consultingchemistry, manufacturing, and controlsadvanced therapiesRNA manufacturingclinical trial supplyQP releasequalified person releasefill and finish services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

eXmoor Pharma Comparables

Compare eXmoor Pharma with similar companies based on industry and business-model similarity.

eXmoor Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RoslinCT
88%
Kincell Bio
88%
Genezen
84%

eXmoor Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 30, 2023
VC RoundMar 11, 2021
GrantFeb 23, 2015

Key People

Founding team and executive leadership

Lucy Foley

Chief Executive Officer

Executive Team

Graham Henderson

Chief Financial Officer

Executive Team

eXmoor Pharma Investors

Notable investors and investment history

eXmoor Pharma investors
InvestorRounds
Kineticos VenturesSeries A
Innovate UKGrant
Medical Research CouncilGrant
MVM Life Science Partners LLPSeries A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors grew 69% MoM, reaching 2.6K.

  • Jun 2, 2025

    Monthly visitors grew 40% MoM, reaching 3.5K.

eXmoor Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

eXmoor Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about eXmoor Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersBristol
Employee Range82
Year Founded2004
Last FundingMay 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?